SEOUL, Zuid-Korea–(BUSINESS WIRE)–CURACLE, een in Korea gevestigd biofarmaceutisch bedrijf heeft vandaag bekendgemaakt dat het een exclusieve licentie- en samenwerkingsovereenkomst is aangegaan met Théa Open Innovation, het dochterbedrijf van Théa, E…
Author: Business Wire
Europe Dry Eye Market and Competitive Landscape Report 2021-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Europe Dry Eye Market and Competitive Landscape – 2021” report has been added to ResearchAndMarkets.com’s offering. Europe Dry Eye Market and Competitive Landscape – 2021, provides comprehensive insights into Dry Eye pipel…
Europe Age-Related Macular Degeneration Market and Competitive Landscape Report 2021-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Europe Age-Related Macular Degeneration Market and Competitive Landscape – 2021” report has been added to ResearchAndMarkets.com’s offering. Europe Age-Related Macular Degeneration Market and Competitive Landscape – 2021, …
CURACLE y Théa anuncian un acuerdo de licencia y colaboración para el desarrollo y comercialización de un tratamiento de administración oral para el edema macular diabético y la degeneración macular exudativa asociada a la edad
SEÚL, Corea del Sur–(BUSINESS WIRE)–CURACLE, una empresa biofarmacéutica coreana, ha anunciado hoy que ha firmado un acuerdo exclusivo de licencia y colaboración con Théa Open Innovation (TOI), la empresa asociada de Théa, la compañía oftalmológica i…
CURACLE et Théa annoncent un accord de licence et de collaboration pour le développement et la commercialisation d'un traitement administré par voie orale pour l'œdème maculaire diabétique et la DMLA humide
SÉOUL, Corée du Sud–(BUSINESS WIRE)–CURACLE, une société biopharmaceutique basée en Corée, a annoncé aujourd’hui avoir conclu avec Théa Open Innovation, la société sœur de Théa, le numéro un européen de l’ophtalmologie indépendante fort de 150 ans d’…
Ocular Therapeutix™ to Present Data at the American Academy of Ophthalmology (AAO) 2021 Virtual Annual Meeting
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announc…
IACTA Pharmaceuticals Receives U.S. Department of Defense Funding of $1 Million to Conduct Preclinical Studies of IC 800 to Treat Pain Relief for Eye Injury
GUAYNABO, Puerto Rico–(BUSINESS WIRE)–IACTA Receives U.S. Department of Defense Funding of $1 Million to Conduct Preclinical Studies of IC 800 to Treat Pain Relief for Eye Injury
Aerie Pharmaceuticals to Announce Third Quarter 2021 Financial Results and Host Conference Call on Thursday, November 4, 2021
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company, announced today that its third quarter 2021 financial results will be released after the market closes on Thursday, November 4, 2021. Follo…
Tilak Healthcare Raises €7m to Deploy Its Remote Vision Monitoring Platform
PARIS–(BUSINESS WIRE)– #chronicdisease–Tilak Healthcare, a pioneering company developing mobile games with medical modules to monitor patients with chronic ophthalmological conditions, has announced a €7 million fundraising round managed by Elaia, w…
Aldeyra Therapeutics Reports Third-Quarter 2021 Financial Results and Recent Corporate Highlights
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company developing novel immune-modulating therapies to treat ocular and systemic diseases, today reported recent corporate highlights and financial…
Global Spectacle Lens Market 2021 – 2026: Growing Demand for Vision Correction in the Age of Digitalization – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Spectacle Lens Market – Growth, Trends, Covid-19 Impact, and Forecasts (2021 – 2026)” report has been added to ResearchAndMarkets.com’s offering. The Spectacle Lens market was valued at USD 45,395 million in 2020, and it i…
Europe Dry Age-Related Macular Degeneration Market and Competitive Landscape Report 2018-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Europe Dry Age-Related Macular Degeneration Market and Competitive Landscape – 2021” report has been added to ResearchAndMarkets.com’s offering. Europe Dry Age-Related Macular Degeneration Market and Competitive Landscape …
CURACLE und Théa geben Lizenzierungs- und Kooperationsvereinbarung für die Entwicklung und Vermarktung einer oral verabreichten Behandlung des diabetischen Makulaödems und der feuchten AMD bekannt
SEOUL, Südkorea–(BUSINESS WIRE)–CURACLE, ein in Korea ansässiges biopharmazeutisches Unternehmen, gab heute die Unterzeichnung einer exklusiven Lizenz- und Kooperationsvereinbarung mit Théa Open Innovation bekannt, dem Schwesterunternehmen von Théa, …
CURACLE e Théa annunciano un accordo di licenza e collaborazione per lo sviluppo e la commercializzazione di un trattamento a somministrazione orale per l’edema maculare diabetico e la degenerazione maculare senile essudativa
SEUL, Corea del Sud–(BUSINESS WIRE)–CURACLE, una società biofarmaceutica coreana, ha annunciato quest’oggi di aver concluso un accordo di licenza e collaborazione esclusivo con Théa Open Innovation, la società sorella di Théa, azienda di oftalmologia…
CURACLE and Théa Announce Licensing and Collaboration Agreement for the Development and Commercialization of Orally Administered Treatment for Diabetic Macular Edema and Wet-AMD
SEOUL, South Korea–(BUSINESS WIRE)–CURACLE signs tech licensing and collaboration deal with leading independent European ophthalmology company Théa in diabetic macular edema and wet-AMD
National Vision Holdings, Inc. Announces Third Quarter 2021 Earnings Release and Conference Call
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its third quarter 2021 financial results before the market opens on Wednesday, November 10, 2021. The Company will host a confer…
Europe Macular Edema Market and Competitive Landscape Report 2021: Pipeline, Epidemiology, Valuations, Drug Sales, Forecast, Drug Forecasts, and Shares 2018-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Europe Macular Edema Market and Competitive Landscape – 2021” report has been added to ResearchAndMarkets.com’s offering. Europe Macular Edema Market and Competitive Landscape – 2021, provides comprehensive insights into M…
Europe Glaucoma Market and Competitive Landscape Report 2021: Pipeline, Epidemiology, Valuations, Drug Sales, Forecast, Drug Forecasts, and Shares 2018-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Europe Glaucoma Market and Competitive Landscape – 2021” report has been added to ResearchAndMarkets.com’s offering. Europe Glaucoma Market and Competitive Landscape – 2021, provides comprehensive insights into Glaucoma pi…
Une étude révèle des preuves accablantes indiquant que le daltonisme entrave l'apprentissage à l'école, rapporte EnChroma
BERKELEY, Californie–(BUSINESS WIRE)–EnChroma, créateur de lunettes contre le daltonisme, a publié aujourd’hui les résultats d’une étude sans précédent, qui démontre clairement l’effet négatif de cette anomalie de la vision sur l’apprentissage de mil…
Studie findet überwältigende Beweise, dass Farbenblindheit schulisches Lernen beeinträchtigt, berichtet EnChroma
BERKELEY, Kalifornien–(BUSINESS WIRE)–EnChroma – Schöpfer von Brillen für Farbenblindheit – hat heute die Ergebnisse einer wegweisenden Studie veröffentlicht, aus der eindeutig die negativen Auswirkungen von Farbenblindheit auf das Lernen für Million…